Genmab
Sign in to saveAlso known as Genmab, Inc
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab (Suzhou) Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US.
Key facts
- Company.name
- Genmab A/S
- Company.logo
- Genmab.svg
- Company.logo_size
- 250px
- Company.type
- Public
- Company.traded_as
- (ADR)OMX Copenhagen 25 component
- Company.founder
- Florian Schönharting and Lisa Drakeman
- Company.location
- Copenhagen, Denmark
- Company.num_locations
- 4 (2023)
- Company.industry
- Biotechnology
- Company.products
- DARZALEX/DARZALEX FASPRO EPKINLY/TEPKINLY Kesimpta RYBREVANT TALVEY TECVAYLI TEPEZZA Tivdak
- Company.revenue
- DKK 16.474 billion (2023)
- Company.operating_income
- DKK 5.321 billion (2023)
- Company.net_income
- DKK 4.352 billion (2023)
- Company.num_employees
- 2,204 (2023)
via Wikipedia infobox
Research organization · ROR
- Type
- Company
- Founded
- 1999
- Location
- Copenhagen, Denmark
- Status
- Active
GRID grid.476284.b · ISNI 0000 0004 0647 0126
Official website
Home | Genmab
Genmab is an international biotech company specializing in antibody therapeutics for the treatment of cancer and other serious diseases
genmab.com →Link to the official site · 7,768 chars · not written by Vinony
~8 min read
Encyclopedic overview
13 sectionsContents
- Technology
- History
- Executive history
- Partnerships
- Products
- Pipeline
- Proprietary Products
- Approved Medicines/Products
- Pipeline, Including Further Development for Approved Medicines
- Programs Incorporating Genmab’s Innovation and Technology
- Approved Medicines/Products
- Pipeline, Partner-owned products incorporating Genmab’s innovation, ≥Phase 2 Development
- References
[Skip to Main](javascript:void(0);)
Excerpted from Wikipedia’s “Genmab” article, available under the CC BY-SA 4.0 licence.